Differences in GFR and Tissue Oxygenation, and Interactions between Stenotic and Contralateral Kidneys in Unilateral Atherosclerotic Renovascular Disease.

BACKGROUND AND OBJECTIVES Atherosclerotic renal artery stenosis (ARAS) can reduce renal blood flow, tissue oxygenation, and GFR. In this study, we sought to examine associations between renal hemodynamics and tissue oxygenation with single-kidney function, pressor hormones, and inflammatory biomarkers in patients with unilateral ARAS undergoing medical therapy alone or stent revascularization. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS Nonrandomized inpatient studies were performed in patients with unilateral ARAS (>60% occlusion) before and 3 months after revascularization (n=10) or medical therapy (n=20) or patients with essential hypertension (n=32) under identical conditions. The primary study outcome was change in single-kidney GFR. Individual kidney hemodynamics and volume were measured using multidetector computed tomography. Tissue oxygenation (using R(2)* as a measure of deoxyhemoglobin) was determined by blood oxygen level-dependent magnetic resonance imaging at 3 T. Renal vein neutrophil gelatinase-associated lipocalin (NGAL), monocyte chemoattractant protein-1 (MCP-1), and plasma renin activity were measured. RESULTS Total GFR did not change over 3 months in either group, but the stenotic kidney (STK) GFR rose over time in the stent compared with the medical group (+2.2[-1.8 to 10.5] versus -5.3[-7.3 to -0.3] ml/min; P=0.03). Contralateral kidney (CLK) GFR declined in the stent group (43.6±19.7 to 36.6±19.5 ml/min; P=0.03). Fractional tissue hypoxia fell in the STK (fraction R(2)* >30/s: 22.1%±20% versus 14.9%±18.3%; P<0.01) after stenting. Renal vein biomarkers correlated with the degree of hypoxia in the STK: NGAL(r=0.3; P=0.01) and MCP-1(r=0.3; P=0.02; more so after stenting). Renal vein NGAL was inversely related to renal blood flow in the STK (r=-0.65; P<0.001). Biomarkers were highly correlated between STK and CLK, NGAL (r=0.94; P<0.001), and MCP-1 (r=0.96; P<0.001). CONCLUSIONS These results showed changes over time in single-kidney GFR that were not evident in parameters of total GFR. Furthermore, they delineate the relationship of measurable tissue hypoxia within the STK and markers of inflammation in human ARAS. Renal vein NGAL and MCP-1 indicated persistent interactions between the ischemic kidney and both CLK and systemic levels of inflammatory cytokines.

[1]  L. Lerman,et al.  Paradigm Shifts in Atherosclerotic Renovascular Disease: Where Are We Now? , 2015, Journal of the American Society of Nephrology : JASN.

[2]  M. Stegall,et al.  Compensatory Hypertrophy of the Remaining Kidney in Medically Complex Living Kidney Donors Over the Long Term , 2015, Transplantation.

[3]  L. Lerman,et al.  Assessment of Renal Artery Stenosis Using Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging Analysis , 2014, Investigative radiology.

[4]  Haixin Hong,et al.  Neutrophil gelatinase-associated lipocalin protects renal tubular epithelial cells in hypoxia–reperfusion by reducing apoptosis , 2014, International Urology and Nephrology.

[5]  Ralph B D'Agostino,et al.  Stenting and medical therapy for atherosclerotic renal-artery stenosis. , 2014, The New England journal of medicine.

[6]  L. Juncos,et al.  Interaction Between Stenotic and Contralateral Kidneys: Unique Features of Each in Unilateral Disease , 2014 .

[7]  L. Lerman,et al.  Human renovascular disease: estimating fractional tissue hypoxia to analyze blood oxygen level-dependent MR. , 2013, Radiology.

[8]  L. Lerman,et al.  Stent Revascularization Restores Cortical Blood Flow and Reverses Tissue Hypoxia in Atherosclerotic Renal Artery Stenosis but Fails to Reverse Inflammatory Pathways or Glomerular Filtration Rate , 2013, Circulation. Cardiovascular interventions.

[9]  L. Lerman,et al.  TGF expression and macrophage accumulation in atherosclerotic renal artery stenosis. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[10]  L. Lerman,et al.  Inflammatory and injury signals released from the post-stenotic human kidney. , 2013, European heart journal.

[11]  W. Yuan,et al.  Neutrophil Gelatinase-Associated Lipocalin (NGAL) May Play a Protective Role Against Rats Ischemia/Reperfusion Renal Injury via Inhibiting Tubular Epithelial Cell Apoptosis , 2013, Renal Failure.

[12]  A. Rule,et al.  Chronic renovascular hypertension is associated with elevated levels of neutrophil gelatinase-associated lipocalin. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  Hwang Gyun Jeon,et al.  Predictors of kidney volume change and delayed kidney function recovery after donor nephrectomy. , 2010, The Journal of urology.

[14]  L. Lerman,et al.  Preserved Oxygenation Despite Reduced Blood Flow in Poststenotic Kidneys in Human Atherosclerotic Renal Artery Stenosis , 2010, Hypertension.

[15]  S. Theocharis,et al.  Clinical implication of plasma neutrophil gelatinase-associated lipocalin (NGAL) concentrations in patients with advanced carotid atherosclerosis , 2010, Clinical chemistry and laboratory medicine.

[16]  C. Baigent,et al.  Revascularization versus medical therapy for renal-artery stenosis. , 2009, The New England journal of medicine.

[17]  L. Lerman,et al.  Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond. , 2009, Progress in cardiovascular diseases.

[18]  R. Lavi,et al.  The chemokine monocyte chemoattractant protein-1 contributes to renal dysfunction in swine renovascular hypertension , 2009, Journal of hypertension.

[19]  L. Lerman,et al.  Comparison of 1.5 and 3 T BOLD MR to Study Oxygenation of Kidney Cortex and Medulla in Human Renovascular Disease , 2009, Investigative radiology.

[20]  C. White,et al.  Ultrasound velocity criteria for renal in-stent restenosis. , 2009, Journal of vascular surgery.

[21]  W. Mali,et al.  Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. , 2009, Annals of internal medicine.

[22]  D. Ovcharenko,et al.  Neutrophil gelatinase-associated lipocalin as a survival factor. , 2005, The Biochemical journal.

[23]  R. D'Agostino,et al.  The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. , 2005, Journal of vascular and interventional radiology : JVIR.

[24]  C. Napoli,et al.  Endothelin-1 receptor blockade prevents renal injury in experimental hypercholesterolemia. , 2003, Kidney international.

[25]  G. Chatellier,et al.  Proteinuria in renal artery occlusion is related to active renin concentration and contralateral kidney size , 2002, Journal of hypertension.

[26]  E. Ritman,et al.  Noninvasive measurement of concurrent single-kidney perfusion, glomerular filtration, and tubular function. , 2001, American journal of physiology. Renal physiology.

[27]  T. Larson,et al.  GFR determined by nonradiolabeled iothalamate using capillary electrophoresis. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  J. Laragh,et al.  Renovascular hypertension: renin measurements to indicate hypersecretion and contralateral suppression, estimate renal plasma flow, and score for surgical curability. , 1973, The American journal of medicine.

[29]  J. Laragh,et al.  The physiology of renin secretion in essential hypertension. Estimation of renin secretion rate and renal plasma flow from peripheral and renal vein renin levels. , 1973, The American journal of medicine.

[30]  H. Goldblatt,et al.  STUDIES ON EXPERIMENTAL HYPERTENSION I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA , 1934 .